[25-NSE] Amedisys Inc SEC Filing
Amedisys Inc (AMED) submitted a Form 25 notification indicating the removal/withdrawal of a class of its securities from listing and/or registration on the Nasdaq Stock Market LLC. The filing lists the issuer name, Nasdaq as the exchange, and the issuer's Baton Rouge address and phone number. The form states the Exchange and the Issuer have complied with the applicable rules governing withdrawal, but the specific rule box selected and any signature or date details are not present in the provided text.
Amedisys Inc (AMED) ha presentato una notifica Form 25 comunicando la rimozione/ritiro di una classe dei suoi titoli dalla quotazione e/o registrazione presso il Nasdaq Stock Market LLC. Il documento indica il nome dell'emittente, il Nasdaq come borsa e riporta l'indirizzo e il numero di telefono dell'emittente a Baton Rouge. Il modulo afferma che la Borsa e l'Emittente hanno rispettato le norme applicabili al ritiro, ma nel testo fornito non compaiono la casella relativa alla regola specifica selezionata né dettagli su firma o data.
Amedisys Inc (AMED) presentó una notificación Form 25 indicando la retirada/retiro de una clase de sus valores de la cotización y/o registro en el Nasdaq Stock Market LLC. La presentación lista el nombre del emisor, Nasdaq como la bolsa y la dirección y el teléfono del emisor en Baton Rouge. El formulario señala que la Bolsa y el Emisor han cumplido con las normas aplicables al retiro, pero en el texto proporcionado no aparecen la casilla de la regla específica seleccionada ni datos de firma o fecha.
Amedisys Inc (AMED)는 자사 증권의 한 종류를 나스닥 증권거래소(Nasdaq Stock Market LLC)에서 상장 및/또는 등록 취소·철회함을 알리는 Form 25 통지를 제출했습니다. 제출서에는 발행인 명, 거래소로서 나스닥 표기, 그리고 발행인의 배턴루지 주소와 전화번호가 기재되어 있습니다. 해당 양식은 거래소와 발행인이 취소 절차에 관한 적용 규정을 준수했음을 명시하고 있으나, 제공된 본문에는 선택된 특정 규정 체크박스나 서명·날짜 관련 세부 사항은 포함되어 있지 않습니다.
Amedisys Inc (AMED) a déposé une notification Form 25 indiquant le retrait/abrogation d’une catégorie de ses titres de la cotation et/ou de l’enregistrement sur le Nasdaq Stock Market LLC. Le dépôt mentionne le nom de l’émetteur, le Nasdaq comme place boursière, ainsi que l’adresse et le numéro de téléphone de l’émetteur à Baton Rouge. Le formulaire indique que la Bourse et l’Émetteur ont respecté les règles applicables au retrait, mais le texte fourni ne contient pas la case relative à la règle spécifique choisie ni de détails de signature ou de date.
Amedisys Inc (AMED) hat eine Form 25-Mitteilung eingereicht, in der die Entfernung/der Rückzug einer Klasse ihrer Wertpapiere von der Notierung und/oder Registrierung an der Nasdaq Stock Market LLC angezeigt wird. Die Einreichung nennt den Emittentennamen, die Nasdaq als Börse sowie die Adresse und Telefonnummer des Emittenten in Baton Rouge. Das Formular besagt, dass die Börse und der Emittent die anwendbaren Regeln für den Rückzug eingehalten haben, aber im vorliegenden Text sind die angekreuzte spezifische Regelbox sowie Angaben zu Unterschrift oder Datum nicht enthalten.
- Exchange and issuer assert compliance with the applicable rules (17 CFR 240.12d2-2(b) and 17 CFR 240.12d-2(c)) for withdrawal from listing/registration
- A class of Amedisys securities is being removed/withdrawn from listing and/or registration on Nasdaq, which is a material change for shareholders
- Key details are missing: the specific class of securities affected, the selected rule checkbox, execution signature, and effective date are not provided in the supplied text
Insights
TL;DR: Form 25 notifies that AMED's securities are being removed from Nasdaq and both the Exchange and issuer assert regulatory compliance.
The filing is procedural: it identifies Amedisys Inc and Nasdaq and states compliance with 17 CFR 240.12d2-2(b) and 17 CFR 240.12d-2(c) regarding withdrawal from listing/registration. The document lacks the executed signature/date fields and does not specify which exact class of securities is affected or whether the removal is voluntary or delisting by Nasdaq, beyond the generic compliance statements. For investors, the material fact present is the removal/withdrawal action; all other material details are absent from the text provided.
TL;DR: The filing signals a change in trading venue/registration status for AMED shares while showing procedural compliance statements.
The Form 25 content is limited but clear that Nasdaq certifies it has grounds for filing and that both Exchange and issuer complied with the referenced regulatory provisions for removal/withdrawal. The absence of the chosen rule checkbox, signature, date, and the specific class description prevents assessment of timing, investor options (e.g., continued OTC trading), or corporate rationale. The disclosure is material but incomplete as presented.
Amedisys Inc (AMED) ha presentato una notifica Form 25 comunicando la rimozione/ritiro di una classe dei suoi titoli dalla quotazione e/o registrazione presso il Nasdaq Stock Market LLC. Il documento indica il nome dell'emittente, il Nasdaq come borsa e riporta l'indirizzo e il numero di telefono dell'emittente a Baton Rouge. Il modulo afferma che la Borsa e l'Emittente hanno rispettato le norme applicabili al ritiro, ma nel testo fornito non compaiono la casella relativa alla regola specifica selezionata né dettagli su firma o data.
Amedisys Inc (AMED) presentó una notificación Form 25 indicando la retirada/retiro de una clase de sus valores de la cotización y/o registro en el Nasdaq Stock Market LLC. La presentación lista el nombre del emisor, Nasdaq como la bolsa y la dirección y el teléfono del emisor en Baton Rouge. El formulario señala que la Bolsa y el Emisor han cumplido con las normas aplicables al retiro, pero en el texto proporcionado no aparecen la casilla de la regla específica seleccionada ni datos de firma o fecha.
Amedisys Inc (AMED)는 자사 증권의 한 종류를 나스닥 증권거래소(Nasdaq Stock Market LLC)에서 상장 및/또는 등록 취소·철회함을 알리는 Form 25 통지를 제출했습니다. 제출서에는 발행인 명, 거래소로서 나스닥 표기, 그리고 발행인의 배턴루지 주소와 전화번호가 기재되어 있습니다. 해당 양식은 거래소와 발행인이 취소 절차에 관한 적용 규정을 준수했음을 명시하고 있으나, 제공된 본문에는 선택된 특정 규정 체크박스나 서명·날짜 관련 세부 사항은 포함되어 있지 않습니다.
Amedisys Inc (AMED) a déposé une notification Form 25 indiquant le retrait/abrogation d’une catégorie de ses titres de la cotation et/ou de l’enregistrement sur le Nasdaq Stock Market LLC. Le dépôt mentionne le nom de l’émetteur, le Nasdaq comme place boursière, ainsi que l’adresse et le numéro de téléphone de l’émetteur à Baton Rouge. Le formulaire indique que la Bourse et l’Émetteur ont respecté les règles applicables au retrait, mais le texte fourni ne contient pas la case relative à la règle spécifique choisie ni de détails de signature ou de date.
Amedisys Inc (AMED) hat eine Form 25-Mitteilung eingereicht, in der die Entfernung/der Rückzug einer Klasse ihrer Wertpapiere von der Notierung und/oder Registrierung an der Nasdaq Stock Market LLC angezeigt wird. Die Einreichung nennt den Emittentennamen, die Nasdaq als Börse sowie die Adresse und Telefonnummer des Emittenten in Baton Rouge. Das Formular besagt, dass die Börse und der Emittent die anwendbaren Regeln für den Rückzug eingehalten haben, aber im vorliegenden Text sind die angekreuzte spezifische Regelbox sowie Angaben zu Unterschrift oder Datum nicht enthalten.
FAQ
What does the Form 25 filing for Amedisys (AMED) indicate?
Which Nasdaq rule provisions are referenced in the AMED Form 25?
Does the provided filing identify which class of AMED securities is removed?
Is there an effective date or signature on the provided Form 25 for AMED?
Where is Amedisys' principal office listed in the filing?
